Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Pharmaceuticals
Pharmaceuticals - Indian - Formulations
183 Cr
Low Risk
41.0
44.0
0.1
9.2
277.00
80.80
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Aptus Pharma Ltd (APPL) is currently trading at 261.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aptus Pharma Ltd operates in the Pharmaceuticals sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Aptus Pharma Ltd has traded between a low of ₹80.80 and a high of ₹277.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aptus Pharma Ltd has a market capitalization of approximately 182.85. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aptus Pharma Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 41.01 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 182.85 Cr, Aptus Pharma Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aptus Pharma Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aptus Pharma Ltd is 41.01. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
4
Neutral
9
Bullish
1
Bearish
12
Neutral
21
Bullish
13
Bearish
8
Neutral
12
Bullish
12
Business Expansion
Aptus Pharma Ltd informed the BSE under Reg.30 that it will expand into life‑saving injectables and ICU care products for severe infections, sepsis and critical care to strengthen prescription, institutional and retail presence.
Business Expansion
Aptus Pharma has initiated expansion into life‑saving injectables and ICU care product categories for severe infections, sepsis and critical care, extending its presence across prescription, institutional and retail segments.
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
173.00 | 230 Cr | 27.20 | 5.12 | 0.26 | 16.63 | 19.07 | 11.42 | |
371.00 | 224 Cr | 20.49 | 3.24 | 1.16 | 13.80 | 18.80 | 11.73 | |
110.00 | 188 Cr | 13.29 | 2.09 | 0.00 | 12.05 | 12.15 | 10.18 | |
261.25 | 183 Cr | 41.01 | 9.15 | 0.00 | 15.67 | 18.38 | 8.59 | |
423.00 | 153 Cr | 10.80 | 0.72 | 0.00 | 8.14 | 10.97 | 6.01 | |
124.00 | 146 Cr | 11.36 | 1.62 | 0.00 | 12.26 | 12.71 | 6.01 |
